BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20563655)

  • 1. Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma.
    Zhao FL; Guo W
    Mol Biol Rep; 2011 Feb; 38(2):1039-45. PubMed ID: 20563655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SDF-1α/CXCR4 signaling pathway in clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
    Li YL; Li YF; Li HF; Lv HQ; Sun DZ
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28559386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of stromal cell-derived factor-1 and CXCR4 in endometrial carcinoma tissues and cell lines].
    Li XP; Zhao D; Gao M; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):458-62. PubMed ID: 17068613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
    Luo HN; Li XP; Liu X; Zhang GH; Liu YL
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
    Iwasa S; Yanagawa T; Fan J; Katoh R
    Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
    Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
    Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.
    Wang L; Wang L; Yang B; Yang Q; Qiao S; Wang Y; Sun Y
    Clin Exp Metastasis; 2009; 26(8):1049-54. PubMed ID: 19859817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
    Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
    J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.
    Li W; Gomez E; Zhang Z
    J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
    Taichman RS; Cooper C; Keller ET; Pienta KJ; Taichman NS; McCauley LK
    Cancer Res; 2002 Mar; 62(6):1832-7. PubMed ID: 11912162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
    Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
    Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
    Hirbe AC; Morgan EA; Weilbaecher KN
    Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.